Back in late January, Rosari Isasi et al. published a policy forum paper in Science that discussed the issues surrounding genome editing policies around the world. Key points discussed include the differences between "permissive" and "restrictive" viewpoints, whether restrictions on clinical applications also apply to research - and how vague legislative language sometimes makes this distinction unclear - and, how thresholds for acceptability have been applied in related contexts.
Nice maps are given that indicate the general level of regulation around the world for this issue and for related topics such as preimplantation diagnosis.
